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Postpartum depression (PPD) affects up to 19% of women, negatively impacting
maternal and infant health. Reductions in plasma oxytocin levels have been associated
with PPD and heritability studies have established a genetic contribution. Epigenetic
regulation of the oxytocin receptor gene (OXTR) has been demonstrated and we
hypothesized that individual epigenetic variability at OXTR may impact the development
of PPD and that such variability may be central to predicting risk. This case-control
study is nested within the Avon Longitudinal Study of Parents and Children and included
269 cases with PPD and 276 controls matched on age group, parity, and presence
or absence of depressive symptoms in pregnancy as assessed by the Edinburgh
Postnatal Depression Scale. OXTR DNA methylation (CpG site -934) and genotype
(rs53576 and rs2254298) were assayed from DNA extracted from blood collected
during pregnancy. Conditional logistic regression was used to estimate odds ratios
(ORs) and 95% confidence intervals (CIs) for the association of elevated symptoms of
PPD with genotype, methylation, and their interaction adjusted for psychosocial factors
(n = 500). There was evidence of an interaction between rs53576 and methylation in
the OXTR gene amongst women who did not have depression prenatally but developed
PPD (p interaction = 0.026, adjusted for covariates, n = 257). Those women with GG
genotype showed 2.63 greater odds of PPD for every 10% increase in methylation
level (95% CI: 1.37, 5.03), whereas methylation was unrelated to PPD amongst “A”
carriers (OR = 1.00, 95% CI: 0.58, 1.73). There was no such interaction among women
with PPD and prenatal depression. These data indicate that epigenetic variation that
decreases expression of OXTR in a susceptible genotype may play a contributory role
in the etiology of PPD.
Keywords: ALSPAC, OXTR, DNA methylation, oxytocin receptor, postpartum depression, rs53576, oxytocin,
epigenetics
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Introduction
Women often experience elevated symptoms of postpartum
depression (PPD) with a prevalence up to 19% (Gaynes et al.,
2005; O’Hara and McCabe, 2013; Wisner et al., 2013). This can
place infants at increased risk for poor behavioral, cognitive,
and social development (Beck, 1998; Tronick and Reck, 2009).
Various psycho-social stress related risk factors for PPD have
been deﬁned (e.g., low social support and adversity) and
heritability of PPD has been described (Corwin et al., 2010),
suggesting the importance of allowing for such factors in genetic
studies. Epigenetic mechanisms, such as DNA methylation,
which modify the transcriptional potential of a gene, may yield
a mechanistic explanation for variability in stress reactivity.
Seminal studies in rodents (Weaver et al., 2004; Murgatroyd
et al., 2009) indicate the importance of early life stress in the
development of the epigenetic and transcriptional landscape of
the genome. These studies highlight the impact of the social
environment on the neuroendocrine system and the impact
of stressors on development and behavior. The key to our
understanding of genetic risk for disorder is to include and
consider epigenetic changes that may be already established
before onset of the disorder.
Oxytocin has a key role in regulating emotion, social
interaction, and stress reactivity (Carter, 1998; Neumann and
Landgraf, 2012). It is also central to normal birth, lactation,
and mother–infant attachment (Carter, 1998; Feldman, 2012). In
addition, reductions in oxytocin measured in plasma (Skrundz
et al., 2011; Stuebe et al., 2013) have been associated with PPD.
Oxytocin exerts its eﬀect on the cell through interaction with the
oxytocin receptor gene (OXTR), a G-protein coupled receptor
that upon ligand binding transduces signal to the nucleus (Gimpl
and Fahrenholz, 2001). Transcription of the OXTR is modulated
by DNA methylation of a group of sites located within the ﬁrst
exon of OXTR (Kusui et al., 2001; Kumsta et al., 2013) and
methylation of these sites is variable in the general population.
Methylation of one of these regulatory sites, OXTR CpG site -
934, has been implicated in autism spectrum disorder (Gregory
et al., 2009), callous-unemotional traits (Dadds et al., 2013), and
individual variability in social perception (Jack et al., 2012; Puglia
et al., 2015) pointing to an important role for the actions of DNA
methylation on OXTR in behavior. In mice, deletion of OXTR
leads to deﬁcits in maternal behavior (Takayanagi et al., 2005;
Nishimori et al., 2008). Taken together, these data indicate the
likely importance of DNA methylation of OXTR as a risk factor
for PPD.
Review of the postpartum and peripartum depression
literature indicates an under representation of PPD genetic
studies, particularly those targeting the oxytonergic system
(Skalkidou et al., 2012; Figueiredo et al., 2014). Depression,
however, has been associated with OXTR single nucleotide
polymorphisms (SNPs) including SNPs rs53576 (Costa et al.,
2009; Riem et al., 2011; Saphire-Bernstein et al., 2011; McQuaid
et al., 2013; Thompson et al., 2014) and rs2254298 (Costa
et al., 2009; Kawamura et al., 2010; Thompson et al., 2011;
Brüne, 2012; Apter-Levy et al., 2013), although these studies
report inconsistent ﬁndings in regard to these alleles conferring
“risk” for depression. The inconsistencies in the reports of
association of these SNPs may depend on ethnicity, background,
the nature of behaviors involved, social salience (Apter-Levy
et al., 2013), social environment (Kawamura et al., 2010), and
individual social factors (Tabak, 2013) in published studies
(Macdonald, 2012; Szyf, 2013; Tabak, 2013). For example, data
indicate that individuals who carry the rs53576_GG genotype
(Bradley et al., 2011, 2013; Sturge-Apple et al., 2012; Lucas-
Thompson and Holman, 2013; McQuaid et al., 2013; Raby
et al., 2013) or the rs2254298_A allele (Thompson et al.,
2011; Brüne, 2012) may be more sensitive to their social
environment. Importantly, among studies of adult depression
McQuaid et al. (2013) report increased depressive symptoms
following early life mistreatment in rs53576_GG individuals and
Bradley et al. (2011) found increased emotional dysregulation
and disordered attachment style with childhood maltreatment
in rs53576_GG individuals. These data suggest that the rs53576
GG genotype may be sensitive to adverse life experience, and the
methylation status of OXTR in this genotype may be important
in understanding PPD.
In the present study, we examined the association between
genetic/epigenetic variation in the OXTR gene (measured in
blood during pregnancy) and PPD (deﬁned as elevated symptoms
of depression 8 weeks after birth). We took into account whether
elevated symptoms of depression were present in pregnancy, as
the proposed association between genetic/epigenetic variation
and PPD may diﬀer between women with or without depression
in pregnancy. Moreover antenatal depression is a known
predictor of PPD. We focused on SNPs rs53576 and rs2254298
and concurrently measured DNAmethylation of OXTR CpG site
-934. We hypothesized that as methylation of OXTR increased,
risk of PPD would increase and that this may occur due
to interaction with a speciﬁc genotype (SNPs rs53576 and
rs2254298).
Materials and Methods
The Study Data Collection
This study utilizes data collected in the Avon Longitudinal
Study of Parents and Children (ALSPAC), a survey of
14,541 pregnancies in women who resided in the area of
Avon, UK, with an expected date of delivery between April
1991 and December 1992. The ALSPAC study enrolled
∼80% of the eligible pregnancies, resulting in a sample
that was demographically similar to the UK population
(Boyd et al., 2013a; Fraser et al., 2013). The study began in
pregnancy, and collected data from self-report questionnaires,
biological samples from mothers and oﬀspring, and medical
records (Golding et al., 2001; Boyd et al., 2013b; Fraser
et al., 2013). Speciﬁcally, blood was sampled in individuals
during pregnancy (between 7 and 41 weeks gestation) during
normal antenatal care medical visits (M = 27.15 weeks,
SD = 8.31). Please note that the study website contains details
of all the data that is available through a fully searchable
data dictionary (http://www.bris.ac.uk/alspac/researchers/
data-access/data-dictionary).
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For detailed description of sample collection please see
the study website: http://www.bristol.ac.uk/alspac/researchers/
resources-available/
A nested case-control strategy was used to determine the
associations between OXTR DNA methylation, OXTR genotype,
and the interaction of methylation and genotype in regard
to PPD. The selection of cases and controls was conﬁned to
those deliveries for which obstetric data had been previously
abstracted; this comprised a non-random group of 8,369
deliveries that were over-weighted with teenage mothers and
depressed mothers. From these deliveries we selected women
with singleton surviving live-births who had given permission
for DNA extraction and analysis. We documented that there
was suﬃcient DNA available; and assured the availability of
information on symptoms of depression both at 32 weeks
gestation and 8 weeks postpartum. We recorded parity (deﬁned
as the number of previous pregnancies resulting in a live- or
still-birth), and maternal age at the time of delivery.
The ALSPAC study was designed to collect data on symptoms
of depression during pregnancy and postnatally using the
Edinburgh Postnatal Depression Scale (EPDS), which has been
validated for use both in pregnancy and postnatally. ALSPAC has
reported the prevalence of a high EPDS score (>12) of 13.6% at
32 weeks prenatally and 9.2% post-delivery (Evans et al., 2001).
For the present study we similarly deﬁne PPD as an EPDS score
>12 at 8 weeks postpartum (Cox et al., 1987). There were 295
such pregnancies, 133 with ≥400 ng/μl and 162 with ≥200–
<400 ng/μl DNA concentration. The cases were only chosen if
matched controls were available. To avoid borderline depression
(EPDS scores of 11–12), control pregnancies were selected to
have an EPDS score <11 at 8 weeks postpartum. For each case,
a control was chosen, as far as possible of the same parity,
maternal age, and depression status at 32 weeks gestation. No
valid controls were available for seven cases and were omitted.
Selection preference was given to controls with the highest DNA
concentration; thereafter selection focused on the primiparae
wherever possible. The ﬁnal distribution of 288 case/control
pairs in the original study design is shown in Supplementary
Table S1.
Measures
Key measures for our analyses include genetic, epigenetic, and
depression variables. Our two genetic measures, SNPs rs2254298
and rs53576, both have three levels that represent genotypes
GG, AG, and AA, and are examined as dichotomous (GG vs.
A allele, with AG and AA combined) due to the small number
of AA participants. The epigenetic variable is DNA methylation
of OXTR CpG site -934, a continuous (%) variable scaled in 10
point units. Depressive symptoms, measured by the EPDS (Cox
et al., 1987) at 32 weeks gestation and at 8 weeks postpartum,
are treated as binary measures to indicate a high likelihood of
depression (>12) and low likelihood of depression (<11). Most
studies using cut-oﬀs between 10 and 13 show 80–90% sensitivity
and speciﬁcity of the EPDS (Myers et al., 2013) to predict clinical
depression and earlier studies in the UK have shown that a cut-oﬀ
of >12 gave the best prediction of clinical depression (Cox et al.,
1987). A validation study in the Avon area compared the results
of a clinical psychiatric interview with the answers given to the set
of EPDS questions – this conﬁrmed the validity of the instrument
for use in the study area (Thorpe et al., 1993).
Potential Confounders
Choice of potential confounders was based on prior ALSPAC
ﬁndings and the postnatal depression literature. Among the
psychosocial variables tested for association with PPD were the
following which were devised using details obtained from the
self-completion questionnaires ﬁlled in by the women during
pregnancy: education level achieved, history of psychopathology
(other than depression), family adversity (an index consisting of
the number of adverse psychosocial factors present), life events
occurring during childhood, life events occurring during the
second half of pregnancy and/or the ﬁrst 2 months after the birth,
social support received by the woman and the social network
available to her. In addition details of mode of delivery (elective
or emergency cesarean, forceps or vacuum extraction, normal
vaginal) and gestational age were obtained from the medical
records.
The Epigenetic and Genetic Variants
The OXTR is located on chromosome 3p25. It spans 19,206
basepairs (GRCh37/hg19 assembly) and contains four exons and
three introns. This gene contains a region within the ﬁrst intron
which is subject to epigenetic control via DNA methylation
(Kusui et al., 2001) and methylation varies between individuals
(Gregory et al., 2009; Jack et al., 2012; Puglia et al., 2015).
Within this gene there are also two genetic variants (D’ = 0.64,
r2 = 0.024) that have been investigated more frequently than
others: rs53576 and rs2254298, which are both situated in the
third intron of the gene. A schematic representation of the gene
and its variants is displayed in Supplementary Figure S1. These
variants have not been found to have any clear functional impact
on the gene although they may be in linkage disequilibrium with
a yet unidentiﬁed functional SNP.
There are a number of possibilities for the impact of SNP and
methylation at the OXTR locus. As stated in the discussion, it is
possible that the rs53576 SNP (or one in linkage disequilibrium
with it) may alter transcription levels and that in combination
with epigenetic modiﬁcation of OXTR (which would then further
decrease expression in a methylation dependent manner), the
levels of expression of the gene would decrease below a critical
threshold that would then begin to impact the carrier in an
alleleXmethylation speciﬁc manner. Alternatively, binding of a
molecule that regulates DNA methylation in this region may be
aﬀected by a polymorphism, which would allow one genotype to
modulate DNA methylation and respond to external cues more
readily than the other. Interestingly, there is an EBF1 (early
B-cell factor 1) binding site adjacent to the methylated region
we studied in OXTR (see UCSC genome browser, GRCh37/hg19,
chr3: 8,810,503-8,810,738) and SNPs occur within the predicted
binding region that are in linkage disequilibrium with rs53576
(Loth et al., 2013). EBF1 has recently been shown to associate
with TET2 (Guilhamon et al., 2013), an enzyme in the DNA
demethylation cascade that produces 5-hydroxymethylcytosine,
another important epigenetic regulatory molecule. Since the
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presence of methylated cytosine is necessary for TET2 activity to
produce 5-hydroxymethylcytosine, it is possible that individuals
who display diﬀerent levels of DNA methylation may have
diﬀerent regulatory potential at this locus. Importantly, EBF1 is
a critical factor in epigenetic regulation of both the brain and the
blood, thus providing a potential link between relevant epigenetic
levels in the two tissues. This molecule has also recently been
identiﬁed in a genome wide screen for SNPs that are associated
with stress (Singh et al., 2014). Clearly, additional research is
needed to determine the functional role of the interactions
described here.
Epigenotyping Procedures
The epigenetic variable is DNA methylation of OXTR CpG
site -934, a continuous (%) variable scaled in 10 point units.
Epigenotyping was performed as previously reported (Jack
et al., 2012). Two hundred nanograms of DNA extracted
from whole blood was subject to bisulﬁte treatment (Kit
MECOV50, Invitrogen, Carlsbad, CA, USA). This converts
all non-methylated cytosines in the genome to uracil and
allows for the downstream detection of methylated cytosines
by sequencing. Ten nanograms of bisulﬁte converted DNA
was used as a template for PCR using a Pyromark PCR
kit (Qiagen, Valencia, CA, USA) and 0.2 uM primers
TSL101F (5′-TTGAGTTTTGGATTTAGATAATTAAGGATT-3′)
and TSL101R (5′-biotin-AATAAAATACCTCCCACTCCTTATT
CCTAA-3′). Samples were ampliﬁed in triplicate using the
following cycling conditions [Step 1: (95◦C/15 min)/1 cycle,
Step 2: (94◦C/30 s, 56◦C/30 s, 72◦C/30 s)/50 cycles, Step 3:
(72◦C/10 min)/1 cycle, Step 4: 4◦C hold]. This ampliﬁes a
region on the coding strand of the OXTR gene that contains
site -934 (GRCh37/hg19, chr3: 8,810,729-8,810,845). PCR
conditions were determined using a set of standards for site
-934 at 0, 25, 50, 75, and 100% methylated. Successful PCR
ampliﬁcation of a single fragment that runs at 116 basepairs
was conﬁrmed using agarose gel electrophoresis for each sample
and replicate. Underlined nucleotides in primer set indicate
insertion of an A or C nucleotide at a variable position(C/T)
due to a CpG site within the primer. All samples were ampliﬁed
in triplicate and randomized for pyrosequencing to account for
plate and run variability. On average, samples deviated from the
mean ± 2.4% (CpG site -934). Pyrosequencing was performed
using primer TSL101S (5′-AGAAGTTATTTTATAATTTTT-
3′) on a Pyromark Q24 using PyroMark Gold Q24 Reagents
(Qiagen, Valencia, CA, USA) per the manufacturer’s protocol.
Each pyrosequencing plate contained a set of standards (0, 25,
50, 75, 100% methylated) to evaluate plate-to-plate variability; on
average standards deviated from the mean less than or equal to
±0.05%. Epigenotypes reported are an average of three replicates.
Genotyping Procedures
DNA isolated from whole blood was ampliﬁed for each subject
by PCR using a Pyromark PCR kit (Qiagen, Valencia, CA,
USA), 10 ng of template, and 0.2 uM primers. The primers
used for this study and PCR conditions can be found in
Supplementary Table S2. Successful PCR ampliﬁcation of a single
fragment that runs at 83 base pairs (rs53576) or 51 basepairs
(rs2254298) was conﬁrmed using agarose gel electrophoresis for
each sample. Pyrosequencing was performed on a Pyromark
Q24 (Qiagen, Valencia, CA, USA) using Pyromark Gold Q24
reagents (Qiagen, Valencia, CA, USA) per the manufacturer’s
reagents and protocol. Genotype distribution (and frequency)
obtained for rs53576 was as follows: 267 G/Gs (48.8%), 226
A/Gs (41.3%), and 54 A/As (9.9%). This distribution does not
deviate from the Hardy–Weinberg equilibrium, χ2(1) = 0.369,
p = 0.543. Genotype distribution (and frequency) obtained for
rs2254298 was as follows: 421 G/Gs (77.0%), 116 A/Gs (21.2%),
and 10 A/As (1.8%). This distribution does not deviate from
the Hardy–Weinberg equilibrium, χ2(1) = 0.369, p = 0.54.
The rs53576 polymorphism was previously genotyped using the
Illumina 660W-quad chip on the DNA of the mother. Of the 458
overlapping samples, 455 (99.3%) were identical.
Statistical Approach
Conditional logistic regression was our primary approach for
investigating epigenetic and genetic eﬀects in this case-control
PPD design. We examined SNPs (rs2254298 and rs53576) and
DNA methylation of CpG site -934 as independent variables,
and their interactions, in predicting PPD; while presence or
absence of depression in pregnancy was examined as a potential
moderator of PPD.Where signiﬁcant three-way interactions were
detected, subgroup analyses were performed in an attempt to
simplify the interpretation. Analyses were restricted to white
women to avoid genetic confounding due to race (non-White
n = 18). Models were tested including main eﬀects, interactions,
and in the case of three-way interactions, all nested two-
way interactions. For adjusted analyses we used ﬁve covariates
identiﬁed using forward and backward stepwise conditional
regression on the nine theoretical confounders.
Missing data on genetic variables resulted in two cases being
lost in unadjusted analyses. Missing data on confounders led
to another 45 cases being lost. This reduced sample size in
adjusted analyses resulted in two strata with two cases (depressive
symptoms during pregnancy, parity = 1 or 3+, and age 35
and older) not matched to any controls. We combined these
uninformative strata with strata having the same depression and
parity characteristics, but diﬀering on age group (30–34 years)
after assessing for comparable ﬁndings. Sensitivity analysis was
conducted by comparing the unadjusted models for all available
cases with unadjusted models on the reduced sample. Crude
and adjusted eﬀects are summarized using odds ratios (ORs),
stratiﬁed by subgroup, to aid in interpretation. All analyses were
performed using SAS 9.3.
Ethics
Ethical approval for the study was obtained from the ALSPAC
Ethics and Law Committee.
Results
Sample Characteristics
The characteristics of the mothers analyzed in this study are
shown in Table 1. In all, 545 mothers of white ethnic origin
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were available in unadjusted analyses, reducing to 500 in adjusted
analyses due to missing data on covariates. Women with and
without PPD were equally distributed in two groups per the case-
control design. Almost half of the cases had depression deﬁned
by EPDS > 12 during pregnancy, and controls were selected to
match. Cases had a range in postpartum EPDS scores of 13–27;
controls had a range of 0–10. Methylation levels ranged from 17.7
to 70.7%, with no diﬀerences in overall averages between cases
and controls (Supplementary Figure S2); both SNPs conformed
to Hardy–Weinberg equilibrium (see Materials and Methods),
the AA genotype was observed for 2% and 10% of the sample
for SNPs rs2254298 and rs53576, respectively. The following ﬁve
confounders were identiﬁed as important predictors of case-
control status: recent life events, social support, family adversity,
childhood events, and poor social network. These were used in
adjusted analyses.
The Effect of OXTR Methylation, Genotype,
and their Interaction on PPD
Our primary hypothesis was that increased methylation of OXTR
enhances risk of PPD in women contingent on OXTR genotype
(rs53576_GG vs. A allele) and that this might diﬀer according
to the presence or absence of depression during pregnancy.
Our ﬁrst modeling goal was to test individual associations
between the two speciﬁed OXTR SNPs (rs53576 and rs2254298)
and OXTR methylation (CpG site -934) with PPD. As shown
in Table 1, neither the SNP variables nor methylation were
signiﬁcantly associated with PPD, and these ﬁndings were
consistent when adjusted for psychosocial covariates (data not
shown).
To understand whether PPD was diﬀerentially related to
methylation, based on genotype and the presence or absence
of depression during pregnancy, models with main eﬀects and
interactions (methylation × SNP × depression and nested
two-way terms) were calculated and simpliﬁed to retain only
signiﬁcant terms and nested components. No genetic/epigenetic
interactions were found to predict PPD in the total sample
(Table 1). However we identiﬁed a signiﬁcant three-way
interaction betweenOXTR rs53576 genotype,OXTRmethylation,
and depression in pregnancy in both unadjusted (p = 0.0192)
and adjusted (p = 0.0081) models (Supplementary Table S3).
The distribution of methylation is shown for each group in
Supplementary Figure S3. For rs2254298, no interactions were
statistically signiﬁcant (p> 0.10).
Adjusted odds ratios (aOR) for PPD related to OXTR
methylation and rs53576 genotype are shown in Table 2 (as
well as the corresponding SNP × methylation p-values, and
exact number of individuals per subgroup) for analyses stratiﬁed
by absence and presence of depression during pregnancy. See
Supplementary Table S4 for a breakdown of each subgroup n by
genotype. The data show:
(i) For the subgroup with no depression in pregnancy (n = 257),
individuals with the rs53576 genotype GG (n = 129)
demonstrated a greater odds of PPD [aOR = 2.63 (95% CI:
1.37, 5.03)] for every 10% increase in methylation, whereas
for A carriers (n = 128), there was no diﬀerence in odds of
PPD regardless of level of methylation [aOR = 1.00 (95%
CI: 0.58, 1.73)]. This is a signiﬁcant interaction (p = 0.026).
Moreover, when individuals with a previous history of
depression were excluded from the analysis, this interaction
remained signiﬁcant (Supplementary Table S5).
(ii) In women with depression in pregnancy, although
methylation and rs53576 had no statistically signiﬁcant
eﬀect on PPD, the trend for A carriers (n = 127) was that
greater methylation was associated with PPD, while the
converse was evident for the GG genotype (n = 116; Table 2).
Discussion
This study has shown a signiﬁcant interaction between the
rs53576 genotype, the degree of methylation at CpG -934
in OXTR, and the presence of prenatal depression on PPD
(p = 0.0081). Further detail showed that women who do not
display depression in pregnancy, but who harbor the rs53576_GG
genotype and display high methylation in OXTR are nearly three
times as likely to develop PPD, in comparison to women of lower
methylation levels or carrying the rs53576 A allele.
Thus ﬁndings from this study argue for the integrative use
of genetic and epigenetic markers in the oxytocin pathway to
better understand and predict risk of psychological disorders in
the postnatal period, a critical period for healthy mother–infant
interaction. These studies also may shed light on the diﬃculty of
replication of genetic eﬀects seenwith phenotypes associated with
rs53576 genotype (Bakermans-Kranenburg and van Ijzendoorn,
2014; Connelly et al., 2014). The net result may be to silence
expression ofOXTR to some degree resulting in the mother being
less sensitive to the eﬀects of oxytocin. This lower sensitivity to
oxytocin may aﬀect the mother’s emotional well-being, bonding
with the baby, and coping with the complexities of caring for a
newborn baby.
Based on earlier work, we hypothesized that methylation
of OXTR inﬂuences levels of gene expression (Kusui et al.,
2001; Gregory et al., 2009), which in turn may have resultant
eﬀects on receptor protein levels and receptor sensitivity to an
oxytocin signal. The ﬂexibility of rs53576_GG individuals may
be rooted in their capacity to modulate expression of this gene
through DNA methylation. There are a few examples in the
literature at other receptor loci (Philibert et al., 2007; Oertel
et al., 2012) suggesting the possibility that the OXTR rs53576
polymorphism (or one that is in linkage disequilibrium with it)
may regulate gene expression. We hypothesize that the combined
eﬀect of polymorphism and methylation may lead to changes
in OXTR gene expression, although as yet no published data
exist to indicate whether the genetic eﬀects at this locus have
an impact on transcription. Additional research is warranted
to determine the functional role of the interactions described
here.
Our ﬁndings have implications with respect to understanding
whether OXTR epigenetic modiﬁcation could interfere with
oxytocin’s protective eﬀect on the perinatal maternal brain
(Brunton and Russell, 2008). Early identiﬁcation of susceptibility
might allow clinical vigilance for the possible development of
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TABLE 1 | Characteristics of postpartum depression cases and matched controls chosen from the ALSPAC Cohorta.
Variable Description Controlb Caseb p-valuec
Total in analysis (n = 545)
N 276 269
Matching criteria
Maternal age <25 71 (25.7) 54 (20.1) 0.3943
25–29 106 (38.4) 113 (42.0)
30–34 77 (27.9) 75 (27.9)
35+ 22 (8.0) 27 (10.0)
Parity 0 120 (43.5) 116 (43.1) 0.6404
1 96 (34.8) 97 (36.1)
2 44 (15.9) 35 (13.0)
3+ 16 (5.8) 21 (7.8)
Depression in pregnancyd No 141 (51.1) 138 (51.3) 0.9601
Yes 135 (48.9) 131 (48.7)
Genetic information (n = 545)
OXTR rs2254298 GG 211 (76.45) 208 (77.32) 0.8090
AA/AG 65 (23.55) 61 (22.68)
OXTR rs53576 GG 137 (49.64) 129 (47.96) 0.6945
AA/AG 139 (50.36) 140 (52.04)
OXTR methylation site -934 % 45.97 [6.80] 46.60 [7.40] 0.2990
Confounders (n = 500)
Life eventse Score 8.71 [7.41] 13.08 [9.87] <0.0001
Social supporte Score 19.05 [5.11] 16.57 [5.51] <0.0001
Family adversitye 0 63 (25.1) 32 (12.9) 0.0005
1+ 188 (74.9) 217 (87.1)
Life events in childhoode 0–3 76 (30.3) 38 (15.3) 0.0001
4+ 175 (69.7) 211 (84.7)
Social networke 24–29 127 (50.6) 89 (35.7) 0.0008
3–23 124 (49.4) 160 (64.3)
aSubsample of Caucasian women.
bValues are reported as either n (%) for categorical variables or mean [SD] for dimensional variables.
cp-values represent the association with case/control status. For categorical variables, the Pearson chi-square test was used while for dimensional variables, Student’s
t-test were used.
dEPDS cut-off <11 and >12.
eMeasured in pregnancy.
PPD, and targeting of preventative interventions. The biologically
at-risk women in this study did not display elevated symptoms
of depression in pregnancy, but went on to display an increased
risk of PPD after birth. This perinatal transition to motherhood
can be a stressful period of changing roles, work obligations,
reduced sleep, anticipating childbirth with anxiety, infant feeding
diﬃculties, and trauma related to the actual birth experience.
It can also be a rewarding time when the mother derives
emotional satisfaction from a close relationship with her baby.
Oxytocin nurtures the maternal brain promoting reduced stress,
emotional well-being, and healthy mother–infant interaction
(Brunton and Russell, 2008). OXTR DNA methylation level may
reﬂect reduced OXTR production and reduce responsiveness
to the protective beneﬁts of endogenous oxytocin during the
perinatal period.
This is the ﬁrst investigation of OXTR as a potential clinical
epigenetic/genetic biomarker associated with PPD and further
research in a population-based study is required before we
can be certain that these results were not derived by chance.
There remains the question as to why we did not ﬁnd an
association among women whose depression had started in
pregnancy. However, it must be recalled that the controls for
this group were, by deﬁnition, also depressed prenatally. In
this comparison set, the controls were chosen for the cases
that were depressed prenatally in order to assess whether there
were OXTR genetic/DNA methylation relationships among the
women who continued to be depressed compared with those
whose depression had resolved by 8 weeks postpartum. What
this study does not do is compare the women who had prenatal
depression with those who did not, regardless of whether she
developed PPD or not. It is important, however, to recall that
the overall interaction (p = 0.0081) included the presence of
prenatal depression – thus indicating that the etiology of PPD
associated with prenatal depression diﬀers from PPD with no
prenatal depression. Thus our ﬁndings may have implications
for the classiﬁcation of the onset of mood disorder related
to pregnancy. In DSM-5 (American Psychiatric Association,
2013) the depressive disorders speciﬁer is “with perinatal onset.”
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TABLE 2 | Unadjusted and adjusteda odds ratios and 95% confidence intervals for postpartum depression by OXTR rs53576 genotype and OXTR
methylation site -934, stratified by presence or absence of depression in pregnancy.
Unadjusted (N = 545) Adjusted(N = 500)
Odds ratio 95% CI p-valueb Odds ratio 95% CI p-valueb
No depression in pregnancy n = 279c∗ n = 257d∗
Methylation (10% change) by rs53576 0.060 0.026
GG 2.07 (1.18, 3.63) 2.63 (1.37, 5.03)
A carrier 1.01 (0.62, 1.64) 1.00 (0.58, 1.73)
Depression in pregnancy n = 266e∗ n = 243f∗
Methylation (10% change) by rs53576 0.172 0.155
GG 0.74 (0.46, 1.19) 0.63 (0.37, 1.09)
A carrier 1.18 (0.71, 1.98) 1.23 (0.61, 2.08)
aAdjusted models control for psychosocial covariates: childhood life events, recent life events, family adversity, social support, and social network.
bp-value for interaction within each group.
cUnadjusted model represents 141 controls and 138 cases with no depression in pregnancy.
dAdjusted model represents 128 controls and 129 cases with no depression in pregnancy.
eUnadjusted model represents 135 controls and 131 cases with depression in pregnancy.
fAdjusted model represents 123 controls and 120 cases with depression in pregnancy.
∗See Supplementary Table S3 for a breakdown of each subgroup n by genotype.
The Table shows the odds ratios for PPD for each 10% increase in DNA methylation; p-values are for interaction between genotype and methylation level within each
prenatal depression division. The overall p-values for three way interaction were 0.0192 (n = 545) and 0.0081 (n = 500) for unadjusted and adjusted interactions
respectively. Main effects are not shown due to the two way interactions.
This speciﬁer refers to depression symptoms with onset during
during pregnancy or in the ﬁrst weeks after delivery. Our
data are consistent with a speciﬁc risk of postpartum onset
of mood disorder in women who were not depressed during
pregnancy.
The general eﬀects of oxytocin are to facilitate positive
experiences and emotion regulation (Feldman et al., 2012;
Carter, 2013). However, individual diﬀerences are common, and
diﬀerential sensitivity to social experiences (whether it be stressful
or supportive) is a hallmark of oxytocin’s functions (Bartz
et al., 2011). From our results we hypothesize that women with
rs53576_GG and higher methylation display such diﬀerential
sensitivity. Although the present study was not designed to
identify interactions with speciﬁc life events or other genetic
vulnerabilities in the women’s pasts that may have precipitated
PPD, it did take account of these features in the analyses
so that the ﬁnal models were independent of psychosocial
inﬂuences.
There are a number of limitations of this study, these
include: (i) the numbers of cases and controls in the study.
Even though there was a large sample of pregnant women
from which to choose, the number of women with PPD was
limited. A way around this would have been to increase the
number of controls per case. (ii) For the women who had PPD
superimposed on prenatal depression, we chose controls matched
for prenatal depression – i.e., controls that recovered from their
prenatal depression. This was an important comparison, but
it could be argued that other control comparisons including
women who did not have prenatal depression might have
been equally informative. (iii) Blood samples were used to
assay DNA methylation at OXTR. Though deﬁnitive data that
relate blood and brain methylation at CpG site -934 are not
available, we have previously shown the utility of this assay in
prediction of brain endophenotypes of social perception (Jack
et al., 2012; Puglia et al., 2015). Even so, the selected tissue may
not accurately reﬂect changes that occur in the brain during
pregnancy. (iv) It is not known if OXTR methylation level in
the blood changes during pregnancy. A detailed study during
pregnancy is warranted to establish the mechanism through
which the reported methylation diﬀerences may diﬀerentially
impact the postpartum mother. (v) Lastly, a tag SNP approach
coupled with analysis of methylation across the OXTR gene
would provide a thorough analysis by assaying the over 250
CpG sites in OXTR, but our goal was to focus on speciﬁc sites
identiﬁed in the published literature. These limitations raise
important issues that can be tested in future studies in other
populations.
Conclusion
Depression is especially detrimental in the ﬁrst year after
birth when the mother’s aﬀect and sensitivity to her infant
shapes the level of mother–infant emotional engagement,
and subsequently impacts the child’s developmental trajectory
(Beck, 1995; Feldman and Eidelman, 2007; Shin et al., 2008).
Thus, identiﬁcation of genetic and epigenetic susceptibility
to depression in pregnancy may be one key element in a
multidisciplinary approach to reduce the development of PPD
and hence the adverse sequelae of depression.
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